SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001213900-20-015494
Filing Date
2020-06-23
Accepted
2020-06-22 17:46:55
Documents
4
Group Members
DAVID S. SILBERSTEIN

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D ea123292-13dsilbers_lantern.htm SC 13D 71397
2 LOCK-UP AGREEMENT, BIOLOGICAL MIMETICS, INC. DATED MAY 14, 2020 ea123292ex99-1_lantern.htm EX-1 23748
3 LOCK-UP AGREEMENT, DAVID SILBERSTEIN DATED MAY 15, 2020 ea123292ex99-2_lantern.htm EX-2 25594
4 JOINT FILING AGREEMENT ea123292ex99-3_lantern.htm EX-3 4160
  Complete submission text file 0001213900-20-015494.txt   126329
Mailing Address
Business Address 8584 VALLRYDRIVE MIDDLETOWN MD 21769 3013714593
BIOLOGICAL MIMETICS INC (Filed by) CIK: 0001052423 (see all company filings)

IRS No.: 000000000
Type: SC 13D

Mailing Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201
Business Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201 972-277-1136
Lantern Pharma Inc. (Subject) CIK: 0001763950 (see all company filings)

IRS No.: 463973463 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91536 | Film No.: 20979769
SIC: 2834 Pharmaceutical Preparations